KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Assets (2016 - 2025)

Elevance Health (ELV) has disclosed Assets for 17 consecutive years, with $122.7 billion as the latest value for Q3 2025.

  • On a quarterly basis, Assets rose 5.33% to $122.7 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $122.7 billion, a 5.33% increase, with the full-year FY2024 number at $116.9 billion, up 7.31% from a year prior.
  • Assets was $122.7 billion for Q3 2025 at Elevance Health, up from $121.9 billion in the prior quarter.
  • In the past five years, Assets ranged from a high of $122.7 billion in Q3 2025 to a low of $95.7 billion in Q1 2021.
  • A 5-year average of $108.1 billion and a median of $109.0 billion in 2023 define the central range for Assets.
  • Peak YoY movement for Assets: increased 16.12% in 2021, then increased 2.62% in 2024.
  • Elevance Health's Assets stood at $97.5 billion in 2021, then grew by 5.44% to $102.8 billion in 2022, then increased by 6.01% to $108.9 billion in 2023, then grew by 7.31% to $116.9 billion in 2024, then increased by 5.01% to $122.7 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Assets are $122.7 billion (Q3 2025), $121.9 billion (Q2 2025), and $119.7 billion (Q1 2025).